Form 4: Encompass Health Director Kevin J. O'Connor Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Kevin J. O'Connor reports acquisition of 1,978 shares of Encompass Health Corp restricted stock units.

Summary

  • On May 2, 2024, Kevin J. O'Connor, a director of Encompass Health Corp, acquired 1,978 shares of Encompass Health Common Stock.
  • The acquisition was an annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.
  • Following the transaction, O'Connor directly owns 8,388 shares of Encompass Health Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a standard executive compensation practice, indicating alignment of interests between management and shareholders.

Positives

  • The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and aligns with standard practices in publicly traded companies.

Stakeholder Impact

  • The acquisition of restricted stock units aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term performance.

Key Dates

DateDescription
05/02/2024Date of transaction: Kevin J. O'Connor acquired 1,978 shares of Encompass Health Common Stock.
05/03/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.